A New Zealand Linkage Study Examining the Associations Between A1C Concentration and Mortality
Open Access
- 1 June 2008
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 31 (6) , 1144-1149
Abstract
OBJECTIVE—To examine associations between A1C concentration and mortality in a New Zealand population. RESEARCH DESIGN AND METHODS—During a Hepatitis Foundation screening campaign for hepatitis B (1999–2001), participants were offered A1C testing. The participants were anonymously linked to the national mortality collection to 31 December 2004. Hazard ratios (HRs) and 95% CIs adjusted for age, ethnicity, smoking, and sex were estimated using Cox regression. RESULTS—There were 47,904 participants (71% Mâori, 12% Pacific, 5% Asian, and 12% other). A1C measurements were categorized as n = 142), 4.0 to n = 12,867), 5.0 to n = 30,222), 6.0 to n = 2,669), and ≥7.0% (n = 1,596); there were also 408 participants with a previous diabetes diagnosis. During the follow-up period, 815 individuals died. In those without a prior diabetes diagnosis, there were steadily increasing HRs from the A1C reference category to the highest category (≥7.0%; HR 2.36 [95% CI 1.72–3.25]). As well as all-cause mortality, A1C was associated with mortality from diseases of the circulatory system; endocrine, nutritional, metabolic, and immunity disorders; and other and unknown causes. Mortality was also elevated in those with a prior diabetes diagnosis (5.19 [3.67–7.35]), but this was only partially explained by their elevated A1C levels. CONCLUSIONS—This is the largest study to date of A1C levels and subsequent mortality risk. It confirms previous findings that A1C levels are strongly associated with subsequent mortality in both men and women without a prior diabetes diagnosis.Keywords
This publication has 20 references indexed in Scilit:
- Association between glycosylated hemoglobin and cancer risk: a New Zealand linkage studyAnnals of Oncology, 2007
- Hemoglobin A1c Predicts Diabetes but Not Cardiovascular Disease in Nondiabetic WomenThe American Journal of Medicine, 2007
- Association between Glycosylated Hemoglobin Level and Cardiovascular and All-Cause Mortality in Type 1 DiabetesAmerican Journal of Epidemiology, 2007
- HbA1c as a screening tool for detection of Type 2 diabetes: a systematic reviewDiabetic Medicine, 2007
- Inappropriately Low Glycated Hemoglobin Values and Hemolysis in HIV-Infected PatientsAIDS Research and Human Retroviruses, 2006
- Low Birth Weight, a Risk Factor for Cardiovascular Diseases in Later Life, Is Already Associated With Elevated Fetal Glycosylated Hemoglobin at BirthCirculation, 2006
- A combination of HbA1c, fasting glucose and BMI is effective in screening for individuals at risk of future type 2 diabetes: OGTT is not neededJournal of Internal Medicine, 2006
- Glycosylated Hemoglobin and Mortality in Patients with Nondiabetic Chronic Kidney DiseaseJournal of the American Society of Nephrology, 2005
- Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes MellitusDiabetes Care, 2002
- GHb Is a Better Predictor of Cardiovascular Disease Than Fasting or Postchallenge Plasma Glucose in Women Without Diabetes: The Rancho Bernardo StudyDiabetes Care, 1996